Inflammatory mediators in gestational diabetes mellitus.
The connection between inflammation and insulin resistance has garnered much interest in the past decade. Epidemiologic as well as experimental data have supported the association. The purpose of this article is to review the current evidence linking inflammatory mediators and gestational diabetes mellitus.
Richardson
Alvie C
AC
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Women and Infants' Hospital of Rhode Island/Brown University School of Medicine, 3rd Floor, Providence, RI 02905, USA.
Carpenter
Marshall W
MW
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D016207:Cytokines / Q000502:physiology; D016640:Diabetes, Gestational / Q000188:drug therapy* / Q000276:immunology* / Q000503:physiopathology; D005260:Female; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007113:Immunity, Innate / Q000502:physiology; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology; D007333:Insulin Resistance / Q000502:physiology; D009765:Obesity / Q000503:physiopathology; D011247:Pregnancy
D000893:Anti-Inflammatory Agents; D016207:Cytokines; D005947:Glucose